Markets:

Overview

News

Currencies

International

Treasuries

Organogenesis Holdings Inc. - Class A (NQ:ORGO)

3.870 -0.100 (-2.52%)

Streaming Delayed Price Updated: 9:52 AM EST, Jan 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organogenesis Holdings Inc. - Class A

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Organogenesis Q2 Earnings Beat Expectations; Sales Jump 79%; Raises FY21 Sales Outlook ↗

August 10, 2021

Organogenesis Holdings Inc (NASDAQ: ORGO) Q2 revenues increased 79% Y/Y to $123.2 million, edging out analysts' average expectation of $107.30 million. The increase...

Via Benzinga

Topics Earnings

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 10, 2021

Gainers Arcturus Therapeutics (NASDAQ:ARCT) shares rose 25.93% to $60.75 during Tuesday's pre-market session. The market value of their outstanding shares is at $1.5...

Via Benzinga

Organogenesis Holdings Inc (ORGO) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

ORGO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Organogenesis Holdings: Q2 Earnings Insights ↗

August 09, 2021

Shares of Organogenesis Holdings (NASDAQ:ORGO) rose in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 400.00% year over...

Via Benzinga

Organogenesis Holdings Insights: Return On Capital Employed ↗

June 24, 2021

Organogenesis Holdings (NASDAQ:ORGO) posted Q1 earnings of $12.62 million, an increase from Q4 of 42.05%. Sales dropped to $102.55 million, a 3.98% decrease between quarters. In...

Via Benzinga

Earnings Scheduled For May 10, 2021 ↗

May 10, 2021

Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report...

Via Benzinga

Stocks That Hit 52-Week Highs On Friday ↗

April 09, 2021

During the morning session on Friday, 178 stocks hit new 52-week highs. Noteworthy Points: Microsoft (NASDAQ:MSFT) was the largest firm on a market cap basis to set...

Via Benzinga

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

Looking Into Organogenesis Holdings's Return On Capital Employed ↗

June 08, 2021

Looking at Q1, Organogenesis Holdings (NASDAQ:ORGO) earned $12.62 million, a 42.05% increase from the preceding quarter. Organogenesis Holdings's sales decreased to $102.55...

Via Benzinga

3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More ↗

May 30, 2021

Wall Street analysts expect the biotech industry to grow significantly soon, with the biotech stocks Organogenesis (ORGO), BioDelivery Sciences (BDSI) and Champions Oncology (CSBR) gaining more...

Via Talk Markets

60 Biggest Movers From Yesterday ↗

May 28, 2021

Gainers Vertex Energy, Inc. (NASDAQ: VTNR) shares climbed 124.2% to settle at $3.99 on Thursday after the company announced plans to acquire a Alabama refinery and related...

Via Benzinga

Why Organogenesis Holdings Blasted 7.7% Higher Today ↗

May 27, 2021

The company will be a component of a high-profile stock index.

Via The Motley Fool

Topics Stocks

41 Stocks Moving In Thursday's Mid-Day Session ↗

May 27, 2021

Gainers 1847 Goedeker Inc. (NYSE: GOED) shares jumped 156.5% to $11.08 after dropping over 8% on Wednesday. Vertex Energy, Inc. (NASDAQ: VTNR) jumped 117% to $3.8604 after the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 27, 2021

Gainers Zosano Pharma (NASDAQ:ZSAN) stock moved upwards by 22.59% to $0.91 during Thursday's pre-market session. The company's market cap stands at $97.3 million....

Via Benzinga

24 Stocks Moving in Thursday's Pre-Market Session ↗

May 27, 2021

Gainers Vertex Energy, Inc. (NASDAQ: VTNR) rose 82% to $3.24 in pre-market trading after the company announced plans to acquire a Alabama refinery and related logistics assets....

Via Benzinga

Organogenesis Holdings Inc (ORGO) Q1 2021 Earnings Call Transcript ↗

May 11, 2021

ORGO earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Organogenesis Holdings: Q1 Earnings Insights ↗

May 10, 2021

Shares of Organogenesis Holdings (NASDAQ:ORGO) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 143.75% year over...

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 10, 2021

Gainers Vir Biotechnology (NASDAQ:VIR) sha...

Via Benzinga

Earnings Outlook for Organogenesis Holdings ↗

May 07, 2021

Organogenesis Holdings (NASDAQ:ORGO) releases its next round of earnings this Monday, May 10. Here is Benzinga's essential guide to Organogenesis Holdings's Q1 earnings report....

Via Benzinga

The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗

May 09, 2021

Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 04, 2021

Gainers Obalon Therapeutics (NASDAQ:OBLN)...

Via Benzinga

Repligen Stock Gets Relative Strength Rating Upgrade With Earnings Due ↗

April 28, 2021

A Relative Strength Rating upgrade for Repligen shows improving technical performance. Will it continue?

Via Investor's Business Daily

Medical Device Maker Quanterix Sees Relative Strength Rating Rise To 86 ↗

April 27, 2021

On Tuesday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating rising into to 86, up from 80 the day before.

Via Investor's Business Daily

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 26, 2021

Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of...

Via Benzinga

Align Technology Nears Buy Point With Earnings Due ↗

April 21, 2021

Align Technology is near a possible buy zone ahead of its next quarterly earnings report, expected on or around April 28.

Via Investor's Business Daily

Cancer Therapy Novocure Stock Still On A High As It Clears Technical Benchmark ↗

April 21, 2021

Cancer therapy Novocure stock had its Relative Strength (RS) Rating upgraded from 90 to 93 Wednesday. It's also an IBD 50 member.

Via Investor's Business Daily

Cancer Therapy Novocure Stock Flashes Renewed Technical Strength ↗

April 14, 2021

Novocure stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 67 to 92.

Via Investor's Business Daily

The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs ↗

April 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.